Cargando…
Phytomedicines and Nutraceuticals: Alternative Therapeutics for Sickle Cell Anemia
Sickle cell anemia is a genetically inherited disease in which the “SS” individual possesses an abnormal beta globin gene. A single base substitution in the gene encoding the human β-globin subunit results in replacement of β6 glutamic acid by valine, leading to the devastating clinical manifestatio...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586489/ https://www.ncbi.nlm.nih.gov/pubmed/23476125 http://dx.doi.org/10.1155/2013/269659 |
_version_ | 1782261310404165632 |
---|---|
author | Imaga, Ngozi Awa |
author_facet | Imaga, Ngozi Awa |
author_sort | Imaga, Ngozi Awa |
collection | PubMed |
description | Sickle cell anemia is a genetically inherited disease in which the “SS” individual possesses an abnormal beta globin gene. A single base substitution in the gene encoding the human β-globin subunit results in replacement of β6 glutamic acid by valine, leading to the devastating clinical manifestations of sickle cell disease. This substitution causes drastic reduction in the solubility of sickle cell hemoglobin (HbS) when deoxygenated. Under these conditions, the HbS molecules polymerize to form long crystalline intracellular mass of fibers which are responsible for the deformation of the biconcave disc shaped erythrocyte into a sickle shape. First-line clinical management of sickle cell anemia include, use of hydroxyurea, folic acid, amino acids supplementation, penicillinprophylaxis, and antimalarial prophylaxis to manage the condition and blood transfusions to stabilize the patient's hemoglobin level. These are quite expensive and have attendant risk factors. However, a bright ray of hope involving research into antisickling properties of medicinal plants has been rewarding. This alternative therapy using phytomedicines has proven to not only reduce crisis but also reverse sickling (in vitro). The immense benefits of phytomedicines and nutraceuticals used in the management of sickle cell anemia are discussed in this paper. |
format | Online Article Text |
id | pubmed-3586489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-35864892013-03-09 Phytomedicines and Nutraceuticals: Alternative Therapeutics for Sickle Cell Anemia Imaga, Ngozi Awa ScientificWorldJournal Review Article Sickle cell anemia is a genetically inherited disease in which the “SS” individual possesses an abnormal beta globin gene. A single base substitution in the gene encoding the human β-globin subunit results in replacement of β6 glutamic acid by valine, leading to the devastating clinical manifestations of sickle cell disease. This substitution causes drastic reduction in the solubility of sickle cell hemoglobin (HbS) when deoxygenated. Under these conditions, the HbS molecules polymerize to form long crystalline intracellular mass of fibers which are responsible for the deformation of the biconcave disc shaped erythrocyte into a sickle shape. First-line clinical management of sickle cell anemia include, use of hydroxyurea, folic acid, amino acids supplementation, penicillinprophylaxis, and antimalarial prophylaxis to manage the condition and blood transfusions to stabilize the patient's hemoglobin level. These are quite expensive and have attendant risk factors. However, a bright ray of hope involving research into antisickling properties of medicinal plants has been rewarding. This alternative therapy using phytomedicines has proven to not only reduce crisis but also reverse sickling (in vitro). The immense benefits of phytomedicines and nutraceuticals used in the management of sickle cell anemia are discussed in this paper. Hindawi Publishing Corporation 2013-02-14 /pmc/articles/PMC3586489/ /pubmed/23476125 http://dx.doi.org/10.1155/2013/269659 Text en Copyright © 2013 Ngozi Awa Imaga. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Imaga, Ngozi Awa Phytomedicines and Nutraceuticals: Alternative Therapeutics for Sickle Cell Anemia |
title | Phytomedicines and Nutraceuticals: Alternative Therapeutics for Sickle Cell Anemia |
title_full | Phytomedicines and Nutraceuticals: Alternative Therapeutics for Sickle Cell Anemia |
title_fullStr | Phytomedicines and Nutraceuticals: Alternative Therapeutics for Sickle Cell Anemia |
title_full_unstemmed | Phytomedicines and Nutraceuticals: Alternative Therapeutics for Sickle Cell Anemia |
title_short | Phytomedicines and Nutraceuticals: Alternative Therapeutics for Sickle Cell Anemia |
title_sort | phytomedicines and nutraceuticals: alternative therapeutics for sickle cell anemia |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586489/ https://www.ncbi.nlm.nih.gov/pubmed/23476125 http://dx.doi.org/10.1155/2013/269659 |
work_keys_str_mv | AT imagangoziawa phytomedicinesandnutraceuticalsalternativetherapeuticsforsicklecellanemia |